Omidria Side Effects
Generic name: ketorolac / phenylephrine ophthalmic
Medically reviewed by Drugs.com. Last updated on Sep 13, 2020.
Note: This document contains side effect information about ketorolac / phenylephrine ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Omidria.
For the Consumer
Side effects requiring immediate medical attention
Check with your doctor or nurse immediately if any of the following side effects occur while taking ketorolac/phenylephrine ophthalmic:
- Decreased vision or other changes in vision
- loss of vision
Get emergency help immediately if any of the following symptoms of overdose occur while taking ketorolac/phenylephrine ophthalmic:
Symptoms of overdose
- fast, pounding, or irregular heartbeat or pulse
- fear or nervousness
Side effects not requiring immediate medical attention
Some side effects of ketorolac / phenylephrine ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Feeling of having something in the eye
- red, sore eyes
For Healthcare Professionals
Applies to ketorolac / phenylephrine ophthalmic: intraocular solution
Very common (10% or more): Anterior chamber inflammation (24%)
Common (1% to 10%): Increased intraocular pressure, posterior capsule opacification, eye irritation, foreign body sensation in the eyes[Ref]
1. "Product Information. Omidria (ketorolac-phenylephrine ophthalmic)." Omeros Corporation, Seattle, WA.
More about Omidria (ketorolac / phenylephrine ophthalmic)
- During Pregnancy
- Dosage Information
- Drug Interactions
- Pricing & Coupons
- Drug class: ophthalmic surgical agents
- FDA Approval History
Related treatment guides
Some side effects may not be reported. You may report them to the FDA.